Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...

A rigorous randomized clinical trial of rizatriptan conducted by UCLA and Mayo Clinic researchers failed to outperform ...

A drug company in Durham wants to expand the reach of a therapy it believes can hit $1 billion in global sales.

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment ...

Novo Nordisk, a leading global healthcare company, announced that the US Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

25 mg oral formulation of Wegovy® (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major ...

It's time to rev up the bike's engines again, as MotoGP 25 is set to release in one month. The bike-racing game returns with all-new features and a more realistic experience of being on the track ...

The study included 13,523 patients in the Department of Veterans Affairs health system aged 65 or older, who had hypertension and were initially treated with hydrochlorothiazide at 25 or 50 mg/d.

SpringWorks has set a wholesale acquisition cost for Gomekli at $206.25 per mg. The company estimates that the average cost of treatment will be approximately $22,000 per month for pediatric ...

Discover comprehensive details about Amlodipine, Valsartan and Hydrochlorothiazide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it ...